Letters from the ECCO President
27April2018

Letter from the ECCO President

Silvio Danese, ECCO President

Silvio Danese
Silvio Danese 
©  ECCO

Dear ECCO friends,

Thank you to everyone for once again making the ECCO Congress, Europe’s most important event in the field of Inflammatory Bowel Disease (IBD), such a wonderful occasion. Held this year in Vienna, the Congress attracted 6,676 participants from over 80 countries and the number of accepted abstracts surpassed 1,000.  Thank you especially to our invited speakers for delivering such exciting presentations and also to the ECCO Committee Members for their hard work and dedication, which helped to make the Congress so successful. 

Posted in ECCO News, Volume 13, Issue 1, Letters from the ECCO President

12December2017

Letter from the ECCO President

Julián Panés, ECCO President

Julian PanesJulián Panés  ©  ECCO

Dear ECCO friends,

We are witnessing an exciting period in the development of new therapies for Inflammatory Bowel Diseases. New therapeutic targets, and new classes of drugs, are being integrated into our therapeutic armamentarium. However, when we consider the proportion of patients who respond to induction therapy and, among those, the fraction who achieve remission during maintenance, the percentage of initially treated patients in whom the disease is satisfactorily controlled over one year does not exceed 15%30%.

Posted in ECCO News, Volume 12, Issue 4, Letters from the ECCO President